Lymphocyte Immunotherapy in Recurrent Pregnancy Loss
Summary
Recurrent pregnancy loss, defined by the occurrence of two or more consecutive miscarriages, affects up to 3% of couples worldwide and often remains without a clear cause. An alloimmune hypothesis posits that insufficient maternal immune tolerance to paternal antigens may contribute to pregnancy failure. Lymphocyte immunotherapy (LIT) seeks to restore tolerance by administering paternal or partner lymphocytes to the mother, thereby inducing mixed lymphocyte reaction blocking factors and shifting cytokine profiles toward a pregnancy-supportive balance. Protocols vary in cell dose, interval and route of administration, and patient selection is usually guided by immune assays such as cross-match tests and measurements of blocking antibodies. While early trials yielded mixed outcomes, recent efforts have refined biomarker-driven approaches, Bayesian modelling for candidate selection and standardised immunomodulatory regimens. LIT offers a personalised intervention with the potential to reduce miscarriage rates, yet its adoption remains constrained by heterogeneous study designs and the need for large prospective trials.
Research from Nature Portfolio
No recent Nature Portfolio content available.
Lymphocyte Immunotherapy in Recurrent Pregnancy Loss publication trend
The graph below shows the total number of articles in lymphocyte immunotherapy in recurrent pregnancy loss across all publications each year (not limited to Nature Index journals).
Technical terms
Lymphocyte immunotherapy (LIT): A treatment involving intradermal or intravenous administration of partner or paternal lymphocytes to induce maternal immune tolerance.
Mixed lymphocyte reaction blocking factors (MLR-Bf): Antibodies or serum factors that inhibit the proliferative response in a mixed lymphocyte culture, reflecting immunological tolerance.
Alloimmune response: An immune reaction mounted by the maternal system against non-self antigens of paternal origin expressed by the embryo.
Th1/Th2/Treg paradigm: A conceptual model describing subsets of T helper cells (Th1 and Th2) and regulatory T cells (Treg) whose balance influences immune tolerance versus inflammation.
Bayesian predictive projection: A statistical method that combines prior data and new evidence to estimate the probability of treatment success and identify influential prognostic factors.
References
- The Effects of LIT and MLR-Bf on Immune Biomarkers and Pregnancy Outcomes in Women With Previous Early Recurrent Miscarriage: A Retrospective Study. Frontiers in Immunology (2021).
- Characterization of mixed lymphocyte reaction blocking antibodies (MLR-Bf) in human pregnancy. BMC Pregnancy and Childbirth (2003).
- Live Birth Rates after Active Immunization with Partner Lymphocytes. Biomedicines (2021).
- A comprehensive Bayesian analysis assessing the effectiveness of lymphocyte immunotherapy for recurrent spontaneous abortion. Life Medicine (2023).
About these summaries
This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.